Cholesterol-lowering oligonucleotides pass preclinical milestone
Published: 20 May 2021
Nature Medicine ; doi:10.1038/d41591-021-00034-4
The publisher has not yet granted permission to display this abstract.
Keywords: Antisense oligonucleotide therapy / Cardiovascular biology / Drug discovery
Scifeed alert for new publicationsNever miss any articles matching your research from any publisher
- Get alerts for new papers matching your research
- Find out the new papers from selected authors
- Updated daily for 49'000+ journals and 6000+ publishers
- Define your Scifeed now
Click here to see the statistics on "Nature Medicine" .